Difference between revisions of "Predicting the Effect of SNPs (PKU)"
(→ARG158GLN) |
(→ARG158GLN) |
||
Line 57: | Line 57: | ||
<figure id="fig:mutationSERARG"> |
<figure id="fig:mutationSERARG"> |
||
<center><small><caption>Aminoacids in the third mutation</caption></small></center> |
<center><small><caption>Aminoacids in the third mutation</caption></small></center> |
||
+ | |||
+ | </figure> |
||
<div style="float: left; width: 25%"> |
<div style="float: left; width: 25%"> |
||
[[Image:2dstructureArginine.png|frame|<caption>2D structure projection of Arginine with the pK-values for each group. For a better referability the c-atoms are labeled according to the common nomenclature</caption>]] |
[[Image:2dstructureArginine.png|frame|<caption>2D structure projection of Arginine with the pK-values for each group. For a better referability the c-atoms are labeled according to the common nomenclature</caption>]] |
||
</div> |
</div> |
||
+ | |||
− | <div style="float: left; width: 25%"> |
||
+ | |||
+ | <div style="float: left; width: 25%"><br><br><br> |
||
[[Image:2dstructureGlutamine.png|frame|left|<caption>2D structure projection of Glutamine with the pK-values for each group. For a better referability the c-atoms are labeled according to the common nomenclature</caption>]] |
[[Image:2dstructureGlutamine.png|frame|left|<caption>2D structure projection of Glutamine with the pK-values for each group. For a better referability the c-atoms are labeled according to the common nomenclature</caption>]] |
||
</div> |
</div> |
||
Line 66: | Line 70: | ||
[[File:Pymol_158_close.png|300px|thumb|right|<caption>Close-up of the mutated glutamine at residue 158 in PheOH. The best fitting rotamer was chosen to minimize severe or smaller collisions (red to green discs) with neighbouring residues. This rotamer appears in 1.7% of mutations according to the PyMol rotamer database.</caption>]] |
[[File:Pymol_158_close.png|300px|thumb|right|<caption>Close-up of the mutated glutamine at residue 158 in PheOH. The best fitting rotamer was chosen to minimize severe or smaller collisions (red to green discs) with neighbouring residues. This rotamer appears in 1.7% of mutations according to the PyMol rotamer database.</caption>]] |
||
</div> |
</div> |
||
+ | |||
<div style="float: left; width: 25%"> |
<div style="float: left; width: 25%"> |
||
[[File:Pymol_158.png|300px|thumb|right|<caption>Mutated glutamine at residue 158 in PheOH. The residue is located in a helix region and is statistically less likely in this type of structure than the original arginine.</caption>]] |
[[File:Pymol_158.png|300px|thumb|right|<caption>Mutated glutamine at residue 158 in PheOH. The residue is located in a helix region and is statistically less likely in this type of structure than the original arginine.</caption>]] |
||
</div> |
</div> |
||
− | </figure> |
||
− | |||
− | |||
<br style="clear:both;"> |
<br style="clear:both;"> |
Revision as of 13:09, 14 June 2012
Contents
Short Introduction
This week's task builds on the data gathered last week. We blindly choose 5 disease causing and 5 harmless SNPs and will try to predict their effect from the sequence change alone. You may find a detailed task description at the usual place and consult our task journal.
Our dataset
we propose the following dataset:
- GLU76GLY
- SER87ARG
- GLN172HIS
- ARG158GLN
- ARG243GLN
- LEU255SER
- MET276VAL
- ALA322GLY
- GLY337VAL
- ARG408TRP
You could check them, if you like.. I put them together 5 minutes ago and already forgot, which are which. ;-)
Investigated SNPS
GLU76GLY
As this mutation results in a change from Glutamic acid to Glycine which have some differences in structure as can bee seen in <xr id="fig:mutationGLUGLY"/> we expect this change to be of rather minor effect. Of course Glutamic acid is charged under biological conditions and Glycine is not, but Glycine is kind of a universal substitution, because it is neither hydrophobic nor hydrophilic. Additionally, as it is the smallest amino acid, it can not produce any sterical problems. Of course it might be that the Glycine can not stabilize any structure, which should be present at this residue, but as we do not have any structural data for this point we only can rely on the physiochemical properties, for which we would say, that these changes are not drastic enough to cause the disease. If the mutation would have occurred rather near the catalytic site, our judgment would have been different as for the strong affinity, of Glutamic acid, to ions, which play a major role in PheOH-activity
- Keychanges: [From negativly charged, polar, strongly hydrophilic, medium sized to neutral, non-polar, non-hydrophilic, small]
Prediction: <figure id="fig:mutationGLUGLY">
</figure>
SER87ARG
we expect that this mutation, which causes a change from Serine to Arginine, has a bigger effect on the protein, than the one above. With this mutation the strength of the effect depends completely on the location of the aminoacid. Both of the amino acids are hydrophilic, but as Arginine is one of the snorkeling, because of its rather hydrophobic stem, the changes can be rather serious(<xr id="fig:mutationSERARG"/>). As the overall change of size and the change in polarity from rather negative to positive and regarding the fact, that arginine is a rather seldom (mostly in the catalytic domain for phosphorylated substrates )used amino acid, we would say, that this is rather a disease causing mutation.
- Keychanges [From neutral, polar, slightly hydrophilic to pos. charged, polar, strongly hydrophilic]
Prediction <figure id="fig:mutationSERARG">
</figure>
ARG158GLN
Keychanges [From pos. charged, polar, strongly hydrophilic to neutral, polar, strongly hydrophilic] <figure id="fig:mutationSERARG">
</figure>
GLN172HIS
From neutral, polar, strongly hydrophilic to neutral, polar, strongly hydrophilic, ring-structure
ARG243GLN
From pos. charged, polar, strongly hydrophilic to neutral, polar, strongly hydrophilic.
LEU255SER
From neutral, non polar, strongly hydrophobic to neutral, polar, slightly hydrophilic.
MET276VAL
From neutral, non-polar, hydrophobic to neutral, non-polar, strongly hydrophobic.
ALA322GLY
From neutral, non-polar, hydrophobic, small to neutral, non-polar, slightly hydrophilic, small.
GLY337VAL
From neutral, non-polar, slightly hydrophilic, small to neutral, non-polar, strongly hydrophobic, medium sized.
ARG408TRP
From pos. charged, polar, strongly hydrophilic, medium sized to neutral, non-polar, slightly hydrophilic, large.
References
A helix propensity scale based on experimental studies of peptides and proteins.